Alaunos Therapeutics, Inc. [TCRT] - Alaunos Therapeutics / Velaris Therapeutics merger
Alaunos Therapeutics, Inc. acquired Velaris Therapeutics, Inc. in a tax-free reorganization, issuing 105,286 shares of Series B Non-Voting Convertible Preferred Stock and 33,054 shares of Series C Non-Voting Convertible Preferred Stock to Velaris stockholders at the closing on October 13, 2026.
Why this matters
Generating analysis…